186 related articles for article (PubMed ID: 35631536)
1. 3,6'- and 1,6'-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation.
Tsai YR; Kim DS; Hsueh SC; Chen KY; Wu JC; Wang JY; Tsou YS; Hwang I; Kim Y; Gil D; Jo EJ; Han BS; Tweedie D; Lecca D; Scerba MT; Selman WR; Hoffer BJ; Greig NH; Chiang YH
Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631536
[TBL] [Abstract][Full Text] [Related]
2. Activity of a Novel Anti-Inflammatory Agent F-3,6'-dithiopomalidomide as a Treatment for Traumatic Brain Injury.
Hsueh SC; Scerba MT; Tweedie D; Lecca D; Kim DS; Baig AM; Kim YK; Hwang I; Kim S; Selman WR; Hoffer BJ; Greig NH
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289711
[TBL] [Abstract][Full Text] [Related]
3. A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.
Kopp KO; Greer ME; Glotfelty EJ; Hsueh SC; Tweedie D; Kim DS; Reale M; Vargesson N; Greig NH
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238617
[TBL] [Abstract][Full Text] [Related]
4. Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury.
Lecca D; Hsueh SC; Luo W; Tweedie D; Kim DS; Baig AM; Vargesson N; Kim YK; Hwang I; Kim S; Hoffer BJ; Chiang YH; Greig NH
J Biomed Sci; 2023 Mar; 30(1):16. PubMed ID: 36872339
[TBL] [Abstract][Full Text] [Related]
5. Pomalidomide Reduces Ischemic Brain Injury in Rodents.
Tsai YR; Tweedie D; Navas-Enamorado I; Scerba MT; Chang CF; Lai JH; Wu JC; Chen YH; Kang SJ; Hoffer BJ; de Cabo R; Greig NH; Chiang YH; Chen KY
Cell Transplant; 2019 Apr; 28(4):439-450. PubMed ID: 31094216
[TBL] [Abstract][Full Text] [Related]
6. 3,6'-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation.
Lin CT; Lecca D; Yang LY; Luo W; Scerba MT; Tweedie D; Huang PS; Jung YJ; Kim DS; Yang CH; Hoffer BJ; Wang JY; Greig NH
Elife; 2020 Jun; 9():. PubMed ID: 32589144
[TBL] [Abstract][Full Text] [Related]
7. 3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury.
Huang PS; Tsai PY; Yang LY; Lecca D; Luo W; Kim DS; Hoffer BJ; Chiang YH; Greig NH; Wang JY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361041
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease.
Palmas MF; Ena A; Burgaletto C; Casu MA; Cantarella G; Carboni E; Etzi M; De Simone A; Fusco G; Cardia MC; Lai F; Picci L; Tweedie D; Scerba MT; Coroneo V; Bernardini R; Greig NH; Pisanu A; Carta AR
Neurotherapeutics; 2022 Jan; 19(1):305-324. PubMed ID: 35072912
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments.
Jung YJ; Tweedie D; Scerba MT; Greig NH
Front Cell Dev Biol; 2019; 7():313. PubMed ID: 31867326
[TBL] [Abstract][Full Text] [Related]
10. Electroacupunctre improves motor impairment via inhibition of microglia-mediated neuroinflammation in the sensorimotor cortex after ischemic stroke.
Liu W; Wang X; Yang S; Huang J; Xue X; Zheng Y; Shang G; Tao J; Chen L
Life Sci; 2016 Apr; 151():313-322. PubMed ID: 26979777
[TBL] [Abstract][Full Text] [Related]
11. Poncirin suppresses lipopolysaccharide (LPS)-induced microglial inflammation and ameliorates brain ischemic injury in experimental stroke in mice.
Yang LX; Chen FY; Yu HL; Liu PY; Bao XY; Xia SN; Gu Y; Xu Y; Cao X
Ann Transl Med; 2020 Nov; 8(21):1344. PubMed ID: 33313089
[TBL] [Abstract][Full Text] [Related]
12. In silico analysis of enantioselective binding of immunomodulatory imide drugs to cereblon.
Murai T; Kawashita N; Tian YS; Takagi T
Springerplus; 2016; 5(1):1122. PubMed ID: 27478739
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).
Gandhi AK; Kang J; Havens CG; Conklin T; Ning Y; Wu L; Ito T; Ando H; Waldman MF; Thakurta A; Klippel A; Handa H; Daniel TO; Schafer PH; Chopra R
Br J Haematol; 2014 Mar; 164(6):811-21. PubMed ID: 24328678
[TBL] [Abstract][Full Text] [Related]
14. Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A
Hawkins KE; DeMars KM; Alexander JC; de Leon LG; Pacheco SC; Graves C; Yang C; McCrea AO; Frankowski JC; Garrett TJ; Febo M; Candelario-Jalil E
Brain Behav; 2017 May; 7(5):e00688. PubMed ID: 28523230
[TBL] [Abstract][Full Text] [Related]
15. Fraxetin alleviates microglia-mediated neuroinflammation after ischemic stroke.
Deng SJ; Ge JW; Xia SN; Zou XX; Bao XY; Gu Y; Xu Y; Meng HL
Ann Transl Med; 2022 Apr; 10(8):439. PubMed ID: 35571418
[TBL] [Abstract][Full Text] [Related]
16. Promoted Generation of T Helper 1-Like Regulatory T Cells After Transient Middle Cerebral Artery Occlusion in Type-2 Diabetic Mice.
Jian L; Hu Y; Gao M; Shu L
Immunol Invest; 2023 Nov; 52(4):482-498. PubMed ID: 37076315
[TBL] [Abstract][Full Text] [Related]
17. Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs.
Gemechu Y; Millrine D; Hashimoto S; Prakash J; Sanchenkova K; Metwally H; Gyanu P; Kang S; Kishimoto T
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):11802-11807. PubMed ID: 30373817
[TBL] [Abstract][Full Text] [Related]
18. Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma.
Charliński G; Vesole DH; Jurczyszyn A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572892
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel indole and indazole-piperazine pyrimidine derivatives with anti-inflammatory and neuroprotective activities for ischemic stroke treatment.
Wang H; Cui E; Li J; Ma X; Jiang X; Du S; Qian S; Du L
Eur J Med Chem; 2022 Nov; 241():114597. PubMed ID: 35931005
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
